Development
Semler Scientific, Inc.
SMLR
$30.25
-$1.18-3.75%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 68.18M | 66.92M | 64.65M | 60.88M | 56.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.18M | 66.92M | 64.65M | 60.88M | 56.69M |
| Cost of Revenue | 6.98M | 4.78M | 4.81M | 4.55M | 4.25M |
| Gross Profit | 61.20M | 62.14M | 59.85M | 56.32M | 52.43M |
| SG&A Expenses | 32.44M | 32.26M | 32.32M | 31.49M | 30.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.19M | 42.97M | 43.13M | 41.36M | 39.48M |
| Operating Income | 22.99M | 23.95M | 21.52M | 19.52M | 17.20M |
| Income Before Tax | 24.10M | 25.24M | 22.86M | 20.38M | 17.69M |
| Income Tax Expenses | 3.52M | 5.67M | 5.12M | 4.45M | 3.37M |
| Earnings from Continuing Operations | 20.58 | 19.58 | 17.74 | 15.93 | 14.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.58M | 19.58M | 17.74M | 15.93M | 14.33M |
| EBIT | 22.99M | 23.95M | 21.52M | 19.52M | 17.20M |
| EBITDA | 23.51M | 24.45M | 22.01M | 20.01M | 17.72M |
| EPS Basic | 3.06 | 2.92 | 2.65 | 2.38 | 2.13 |
| Normalized Basic EPS | 2.37 | 2.43 | 2.15 | 1.91 | 1.64 |
| EPS Diluted | 2.63 | 2.50 | 2.25 | 2.01 | 1.79 |
| Normalized Diluted EPS | 2.03 | 2.07 | 1.83 | 1.61 | 1.38 |
| Average Basic Shares Outstanding | 26.93M | 26.82M | 26.78M | 26.83M | 26.91M |
| Average Diluted Shares Outstanding | 31.32M | 31.50M | 31.62M | 31.78M | 32.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |